CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 59 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $178,000 | -76.1% | 84,357 | -67.3% | 0.00% | – |
| Q1 2021 | $745,000 | +19.6% | 257,742 | -11.4% | 0.00% | – |
| Q4 2020 | $623,000 | -65.7% | 290,850 | -0.9% | 0.00% | – |
| Q3 2020 | $1,817,000 | +82.8% | 293,422 | +89.8% | 0.00% | – |
| Q2 2020 | $994,000 | +209.7% | 154,587 | +99.8% | 0.00% | – |
| Q1 2020 | $321,000 | -24.8% | 77,384 | +7.1% | 0.00% | – |
| Q4 2019 | $427,000 | +36.0% | 72,246 | +24.2% | 0.00% | – |
| Q3 2019 | $314,000 | -22.5% | 58,159 | +15.9% | 0.00% | – |
| Q2 2019 | $405,000 | +77.6% | 50,193 | +74.7% | 0.00% | – |
| Q1 2019 | $228,000 | +212.3% | 28,735 | +71.6% | 0.00% | – |
| Q4 2018 | $73,000 | – | 16,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|